The healthcare sector is trading higher, driven by a positive shift in sentiment towards the biotechnology industry. Investment bank Goldman Sachs reinitiated coverage on several biotech companies with a favorable outlook, citing the sector's resilience, ongoing acquisition activity, and a supportive regulatory environment. This has sparked renewed investor interest in the broader healthcare space, leading to outperformance.